---
title: "The pan-European Stoxx 600 index rises, Novo Nordisk's stock price falls 4% after earnings"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/264474319.md"
description: "The Swedish central bank kept interest rates unchanged, and concerns about the valuation of technology stocks led to a rise in European stock markets on Wednesday, with the pan-European Stoxx 600 index up 0.4%. Danish pharmaceutical company Novo Nordisk saw its stock price drop by more than 4% after its earnings announcement. Germany's BMW reported an EBIT of €2.3 billion for the third quarter, in line with expectations, and its stock price rose by more than 6%. The UK's FTSE 100 index rose by 66 points, Germany's DAX index increased by 131 points, and France's CAC 40 index gained 27 points"
datetime: "2025-11-05T15:58:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264474319.md)
  - [en](https://longbridge.com/en/news/264474319.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264474319.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/264474319.md) | [English](https://longbridge.com/en/news/264474319.md)


# The pan-European Stoxx 600 index rises, Novo Nordisk's stock price falls 4% after earnings

The Swedish central bank announced that it would maintain interest rates, while concerns about overvalued tech stocks led to a rise in European stock markets on Wednesday. The pan-European Stoxx 600 index rose by 0.4%.

Danish pharmaceutical company Novo Nordisk saw its stock price drop by more than 4% after announcing its earnings. German automaker BMW reported an EBIT of €2.3 billion for the third quarter, in line with analysts' expectations, and its stock price rose by more than 6%.

The UK FTSE 100 index rose by 66 points or 0.7%, closing at 9,782 points. The German DAX index rose by 131 points or 0.6%, closing at 24,080 points. The French CAC 40 index rose by 27 points or 0.3%, closing at 8,094 points

### 相關股票

- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-HK/quote/NVO.US.md)

## 相關資訊與研究

- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/zh-HK/news/281206892.md)
- [Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program](https://longbridge.com/zh-HK/news/280885256.md)
- [Novo Nordisk A/S Approves Final Dividend for 2025, Payable in March 2026](https://longbridge.com/zh-HK/news/280694679.md)
- [UK Regulator Recommends Novo Nordisk's Wegovy for People at Risk of Heart Attacks, Strokes](https://longbridge.com/zh-HK/news/281294814.md)
- [<![CDATA[Novo Nordisk Launches Multi-Month Subscription Program for Wegovy ]]>](https://longbridge.com/zh-HK/news/281216333.md)